<DOC>
	<DOCNO>NCT02264301</DOCNO>
	<brief_summary>The purpose study evaluate effect Qingkailing injection versus Puerarin injection withdrawal rate corticosteroid patient active rheumatoid arthritis .</brief_summary>
	<brief_title>Qingkailing Injection Versus Puerarin Injection Withdrawal Rate Corticosteroids Patients With Active Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Puerarin</mesh_term>
	<criteria>active RA without take medication treatment active RA least 4 last week age 18 75 year without conflict write , informed consent sign prior enrollment . include clinical trial within last 4 week abnormal liver kidney function ( 1 time high normal ) serious cardiovascular disease hematologic disease pregnancy , lactation period pregnancy plan severe gastrointestinal disease contraindication allergic test drug treatment drug within 1 previous week , might affect result trial , nonsteroidal antiinflammatory drug , steroidal antiinflammatory drug , immunosuppressant , antiulcer drug compatible trial medication , circumstance discretion investigator without legal capacity limit legal capacity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>